Japanese Phase 1 Multiple Ascending Dose Study

NCT01515202 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: BMS-823778
DRUG: BMS-823778
DRUG: BMS-823778
DRUG: BMS-823778
DRUG: Placebo matching with BMS-823778

Sponsor

Bristol-Myers Squibb